カテゴリ： Transparency Market Research, 世界, 医療/バイオ

In Vivo毒物学の世界市場2023～2033：製品別、検査別、検査施設別、毒性エンドポイント別、エンドユーザー別、地域別

■ 英語タイトル：Global In Vivo Toxicology Market by Product (Instruments, Consumables), by Test Type (Acute, Sub-acute, Sub-chronic, Chronic Test Type), by Testing Facility (Outsourced Testing Facility, In-house Testing Facility), by Toxicity End Point (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental & Reproductive Toxicity, Other Toxicity End Points), by End User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - 2023 to 2033

調査会社Transparency Market Research社が発行したリサーチレポート（データ管理コード：TMR23MA041）■ 発行会社/調査会社：Transparency Market Research
■ 商品コード：TMR23MA041
■ 発行日：2023年3月29日
■ 調査対象地域：北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ
■ 産業分野：医療
■ ページ数：250
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[In Vivo毒物学の世界市場2023～2033：製品別、検査別、検査施設別、毒性エンドポイント別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Transparency Market Research社の当調査レポートでは、世界のIn Vivo毒物学市場規模が、2023年の52億ドルから2033年に95億ドルとなり、予測期間中に年平均成長率5.6%で拡大すると展望しています。本書は、In Vivo毒物学の世界市場にフォーカスし、市場状況や今後の動向などをまとめた資料です。エグゼクティブサマリー、市場概要、市場背景、製品別（器具、消耗品）分析、検査別（急性、亜急性、亜慢性、慢性検査）分析、検査施設別（外部委託検査施設、インハウス検査施設）分析、毒性エンドポイント別（免疫毒性、全身毒性、発がん性、遺伝毒性、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、市場参入企業として、Charles River Laboratories,、THE JACKSON LABORATORY、Envigo、Taconic Biosciences, Inc.、genOway、Thermo Fisher Scientific、Danaher Corporation、Waters Corporation、Agilent Technologies、Shimadzu Corporation、Bruker Corporation、PerkinElmer、Merck KGaA、BioSpace、Bio-Rad Laboratoriesなどの情報が含まれています。
・エグゼクティブサマリー
・市場概要
・市場背景
・世界のIn Vivo毒物学市場規模：製品別
- 器具の市場規模
- 消耗品の市場規模
・世界のIn Vivo毒物学市場規模：検査別
- 急性検査の市場規模
- 亜急性検査の市場規模
- 亜慢性検査の市場規模
- 慢性検査の市場規模
・世界のIn Vivo毒物学市場規模：検査施設別
- 外部委託検査施設における市場規模
- インハウス検査施設における市場規模
・世界のIn Vivo毒物学市場規模：毒性エンドポイント別
- 免疫毒性検査の市場規模
- 全身毒性検査の市場規模
- 発がん性検査の市場規模
- 遺伝毒性検査の市場規模
- その他毒性エンドポイントの市場規模
・世界のIn Vivo毒物学市場規模：地域別
- 北米のIn Vivo毒物学市場規模
- 中南米のIn Vivo毒物学市場規模
- ヨーロッパのIn Vivo毒物学市場規模
- アジア太平洋のIn Vivo毒物学市場規模
- 中東・アフリカのIn Vivo毒物学市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

In Vivo Toxicology Market – Scope of Report
TMR’s report on the global in vivo toxicology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global in vivo toxicology market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vivo toxicology market from 2023 to 2033.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vivo toxicology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vivo toxicology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vivo toxicology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vivo toxicology market.

The report delves into the competitive landscape of the global in vivo toxicology market. Key players operating in the global in vivo toxicology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vivo toxicology market profiled in this report.

Key Questions Answered in Global In Vivo Toxicology Market Report
• What is the sales/revenue generated by in vivo toxicology across all regions during the forecast period?
• What are the opportunities in the global in vivo toxicology market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

In Vivo Toxicology Market – Research Objectives and Research Approach
The comprehensive report on the global in vivo toxicology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in vivo toxicology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vivo toxicology market.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast, 2023-2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Product
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
        5.3.1. Instruments
        5.3.2. Consumables
            5.3.2.1. Reagents & Kits
            5.3.2.2. Animal Models
    5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
    5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Test Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018-2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023-2033
        6.3.1. Acute
        6.3.2. Sub-acute
        6.3.3. Sub-chronic
        6.3.4. Chronic Test Type
    6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018-2022
    6.5. Absolute $ Opportunity Analysis By Test Type, 2023-2033
7. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Testing Facility
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis By Testing Facility , 2018-2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Testing Facility , 2023-2033
        7.3.1. Outsourced Testing Facility
        7.3.2. In-house Testing Facility
    7.4. Y-o-Y Growth Trend Analysis By Testing Facility , 2018-2022
    7.5. Absolute $ Opportunity Analysis By Testing Facility , 2023-2033
8. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Toxicity End Point
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) Analysis By Toxicity End Point, 2018-2022
    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Toxicity End Point, 2023-2033
        8.3.1. Immunotoxicity
        8.3.2. Systemic Toxicity
        8.3.3. Carcinogenicity
        8.3.4. Genotoxicity
        8.3.5. Developmental & Reproductive Toxicity
        8.3.6. Other Toxicity End Points
    8.4. Y-o-Y Growth Trend Analysis By Toxicity End Point, 2018-2022
    8.5. Absolute $ Opportunity Analysis By Toxicity End Point, 2023-2033
9. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By End User
    9.1. Introduction / Key Findings
    9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
        9.3.1. Academic and Research Institutes
        9.3.2. Pharmaceutical & Biotechnology Companies
        9.3.3. Contract Research Organizations
        9.3.4. Others
    9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
    9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Region
    10.1. Introduction
    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific
        10.3.5. Middle East and Africa
    10.4. Market Attractiveness Analysis By Region
11. North America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        11.2.1. By Country
            11.2.1.1. U.S.
            11.2.1.2. Canada
        11.2.2. By Product
        11.2.3. By Test Type
        11.2.4. By Testing Facility
        11.2.5. By Toxicity End Point
        11.2.6. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product
        11.3.3. By Test Type
        11.3.4. By Testing Facility
        11.3.5. By Toxicity End Point
        11.3.6. By End User
    11.4. Key Takeaways
12. Latin America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        12.2.1. By Country
            12.2.1.1. Brazil
            12.2.1.2. Mexico
            12.2.1.3. Rest of Latin America
        12.2.2. By Product
        12.2.3. By Test Type
        12.2.4. By Testing Facility
        12.2.5. By Toxicity End Point
        12.2.6. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product
        12.3.3. By Test Type
        12.3.4. By Testing Facility
        12.3.5. By Toxicity End Point
        12.3.6. By End User
    12.4. Key Takeaways
13. Europe In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        13.2.1. By Country
            13.2.1.1. U.K.
            13.2.1.2. Spain
            13.2.1.3. Germany
            13.2.1.4. Italy
            13.2.1.5. France
            13.2.1.6. Rest of Europe
        13.2.2. By Product
        13.2.3. By Test Type
        13.2.4. By Testing Facility
        13.2.5. By Toxicity End Point
        13.2.6. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product
        13.3.3. By Test Type
        13.3.4. By Testing Facility
        13.3.5. By Toxicity End Point
        13.3.6. By End User
    13.4. Key Takeaways
14. Asia Pacific In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. India
            14.2.1.4. Rest of Asia Pacific
        14.2.2. By Product
        14.2.3. By Test Type
        14.2.4. By Testing Facility
        14.2.5. By Toxicity End Point
        14.2.6. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product
        14.3.3. By Test Type
        14.3.4. By Testing Facility
        14.3.5. By Toxicity End Point
        14.3.6. By End User
    14.4. Key Takeaways
15. Middle East and Africa In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
        15.2.1. By Country
            15.2.1.1. South Africa
            15.2.1.2. GCC Countries
            15.2.1.3. Rest of Middle East and Africa
        15.2.2. By Product
        15.2.3. By Test Type
        15.2.4. By Testing Facility
        15.2.5. By Toxicity End Point
        15.2.6. By End User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product
        15.3.3. By Test Type
        15.3.4. By Testing Facility
        15.3.5. By Toxicity End Point
        15.3.6. By End User
    15.4. Key Takeaways
16. Key Countries In Vivo Toxicology Market Analysis
    16.1. U.S.
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Product
            16.1.2.2. By Test Type
            16.1.2.3. By Testing Facility
            16.1.2.4. By Toxicity End Point
            16.1.2.5. By End User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Product
            16.2.2.2. By Test Type
            16.2.2.3. By Testing Facility
            16.2.2.4. By Toxicity End Point
            16.2.2.5. By End User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Product
            16.3.2.2. By Test Type
            16.3.2.3. By Testing Facility
            16.3.2.4. By Toxicity End Point
            16.3.2.5. By End User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Product
            16.4.2.2. By Test Type
            16.4.2.3. By Testing Facility
            16.4.2.4. By Toxicity End Point
            16.4.2.5. By End User
    16.5. U.K.
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Product
            16.5.2.2. By Test Type
            16.5.2.3. By Testing Facility
            16.5.2.4. By Toxicity End Point
            16.5.2.5. By End User
    16.6. Spain
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Product
            16.6.2.2. By Test Type
            16.6.2.3. By Testing Facility
            16.6.2.4. By Toxicity End Point
            16.6.2.5. By End User
    16.7. Germany
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Product
            16.7.2.2. By Test Type
            16.7.2.3. By Testing Facility
            16.7.2.4. By Toxicity End Point
            16.7.2.5. By End User
    16.8. Italy
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Product
            16.8.2.2. By Test Type
            16.8.2.3. By Testing Facility
            16.8.2.4. By Toxicity End Point
            16.8.2.5. By End User
    16.9. France
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Product
            16.9.2.2. By Test Type
            16.9.2.3. By Testing Facility
            16.9.2.4. By Toxicity End Point
            16.9.2.5. By End User
    16.10. China
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Product
            16.10.2.2. By Test Type
            16.10.2.3. By Testing Facility
            16.10.2.4. By Toxicity End Point
            16.10.2.5. By End User
    16.11. Japan
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Product
            16.11.2.2. By Test Type
            16.11.2.3. By Testing Facility
            16.11.2.4. By Toxicity End Point
            16.11.2.5. By End User
    16.12. India
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Product
            16.12.2.2. By Test Type
            16.12.2.3. By Testing Facility
            16.12.2.4. By Toxicity End Point
            16.12.2.5. By End User
    16.13. South Africa
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Product
            16.13.2.2. By Test Type
            16.13.2.3. By Testing Facility
            16.13.2.4. By Toxicity End Point
            16.13.2.5. By End User
    16.14. GCC Countries
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Product
            16.14.2.2. By Test Type
            16.14.2.3. By Testing Facility
            16.14.2.4. By Toxicity End Point
            16.14.2.5. By End User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Product
        17.3.3. By Test Type
        17.3.4. By Testing Facility
        17.3.5. By Toxicity End Point
        17.3.6. By End User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Charles River Laboratories
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. THE JACKSON LABORATORY
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. Envigo
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. Taconic Biosciences, Inc.
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. genOway
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. Thermo Fisher Scientific
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. Danaher Corporation
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Waters Corporation
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Agilent Technologies
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. Shimadzu Corporation
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
        18.1.11. Bruker Corporation
            18.1.11.1. Overview
            18.1.11.2. Product Portfolio
            18.1.11.3. Profitability by Market Segments
            18.1.11.4. Sales Footprint
            18.1.11.5. Strategy Overview
                18.1.11.5.1. Marketing Strategy
        18.1.12. PerkinElmer
            18.1.12.1. Overview
            18.1.12.2. Product Portfolio
            18.1.12.3. Profitability by Market Segments
            18.1.12.4. Sales Footprint
            18.1.12.5. Strategy Overview
                18.1.12.5.1. Marketing Strategy
        18.1.13. Merck KGaA
            18.1.13.1. Overview
            18.1.13.2. Product Portfolio
            18.1.13.3. Profitability by Market Segments
            18.1.13.4. Sales Footprint
            18.1.13.5. Strategy Overview
                18.1.13.5.1. Marketing Strategy
        18.1.14. BioSpace
            18.1.14.1. Overview
            18.1.14.2. Product Portfolio
            18.1.14.3. Profitability by Market Segments
            18.1.14.4. Sales Footprint
            18.1.14.5. Strategy Overview
                18.1.14.5.1. Marketing Strategy
        18.1.15. Bio-Rad Laboratories
            18.1.15.1. Overview
            18.1.15.2. Product Portfolio
            18.1.15.3. Profitability by Market Segments
            18.1.15.4. Sales Footprint
            18.1.15.5. Strategy Overview
                18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology

List of Tables

Table 1: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Region, 2018-2033

Table 2: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 3: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 4: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 5: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 6: Global In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

Table 7: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033

Table 8: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 9: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 10: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 11: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 12: North America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

Table 13: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033

Table 14: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 15: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 16: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 17: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 18: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

Table 19: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033

Table 20: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 21: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 22: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 23: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 24: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

Table 25: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033

Table 26: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 27: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 28: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 29: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 30: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

Table 31: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033

Table 32: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033

Table 33: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033

Table 34: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033

Table 35: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033

Table 36: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 研究用抗体＆試薬の世界市場2023～2033：製品別、形態別、ソース別、技術別、用途別、エンドユーザー別、地域別
  • コラーゲン＆ゼラチンの世界市場2023～2033：ソース別、用途別、エンドユーザー別、地域別
  • 遺伝子合成の世界市場（2023～2033）：手法別、サービス種類別、用途別、エンドユーザー別、地域別
  • 遠心式血液ポンプの世界市場（2023～2033）：種類別、エンドユーザー別
  • 眼科用ペリメーターの世界市場（2023～2033）：製品別、エンドユーザー別、地域別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(TMR23MA041 )"In Vivo毒物学の世界市場2023～2033：製品別、検査別、検査施設別、毒性エンドポイント別、エンドユーザー別、地域別" (英文：Global In Vivo Toxicology Market by Product (Instruments, Consumables), by Test Type (Acute, Sub-acute, Sub-chronic, Chronic Test Type), by Testing Facility (Outsourced Testing Facility, In-house Testing Facility), by Toxicity End Point (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental & Reproductive Toxicity, Other Toxicity End Points), by End User (Academic and Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - 2023 to 2033)はTransparency Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。